Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease

Lignende værker

• In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
  af: Khater, Ibrahim, et al.
  Udgivet: (2021)
• Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis
  af: Hakmi, Mohammed, et al.
  Udgivet: (2020)
• A molecular docking study of potential inhibitors and repurposed drugs against SARS-CoV-2 main protease enzyme()
  af: Ercan, Selami, et al.
  Udgivet: (2021)
• An Interpretable Deep Learning and Molecular Docking Framework for Repurposing Existing Drugs as Inhibitors of SARS-CoV-2 Main Protease
  af: Juan Huang, et al.
  Udgivet: (2025-08-01)
• Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors
  af: Fiorucci, Diego, et al.
  Udgivet: (2020)